BAXTER BELGIUM
De berekende faillissementskans van BAXTER BELGIUM over 12 maanden bedraagt 0,8% (laag). Het bedrijf is actief sinds 2003 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 22 jaar |
| Vestigingen | 2 |
| Publicaties | 28 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2024 | ander | 10-07-2025 | 2025-00272750 |
| 31-12-2023 | ander | 09-07-2024 | 2024-00229660 |
| 31-12-2022 | ander | 10-07-2023 | 2023-00218767 |
| 31-12-2021 | ander | 14-07-2022 | 2022-20184226 |
| 31-12-2020 | ander | 31-08-2021 | 2021-58400587 |
| 31-12-2019 | volledig | 21-10-2020 | 2020-62100357 |
| 31-12-2018 | volledig | 02-07-2019 | 2019-27100061 |
| 31-12-2017 | volledig | 27-07-2018 | 2018-39100206 |
| 31-12-2016 | volledig | 22-06-2017 | 2017-20500576 |
| 31-12-2015 | volledig | 05-07-2016 | 2016-27500226 |
| NACE primair | Groothandel(46460) |
| Rechtsvorm | BV(610) |
| Oprichtingsdatum | 20-10-2003 |
| Status | Actief |
| Postcode | 7860 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 55023C0872/00Y000 | Wallonië | 9,3 ha | 1 · 4,0 ha | 15,5 m |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
29-07-2025 3 bestuurders benoemd
- SRL PwC Reviseurs d'Entreprises, Commissaire
- Romain Seffer SRL, Représentant du commissaire
- Romain Seffer, Représentant permanent du commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SRL PwC Reviseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant du commissaire",
"person": {
"rrn": null,
"name": "Romain Seffer SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent du commissaire",
"person": {
"rrn": null,
"name": "Romain Seffer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}08-07-2024 Marc Herman Jacobs neemt ontslag als administrateur de catégorie a
- Marc Herman Jacobs, Administrateur de catégorie a
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Marc Herman Jacobs",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}17-05-2024 Kapitaalvermindering van €8.877,09 tot €56.108,21
- €64.985,30 → €56.108,21
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 56108.21,
"delta_eur": -8877.090000000004,
"before_eur": 64985.3,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}20-03-2024 Publicatie in het Belgisch Staatsblad, Diversen
Technische details
{
"stage": "proposal",
"notary": {
"name": "Herman Jacobs",
"firm_city": null,
"firm_name": null,
"office_city": "Tournai",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-03-20",
"filing_date": "2024-03-11",
"act_kind_objet": "Projet de scission partielle"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-03-11",
"unanimous": null
},
"conversion": null,
"detected_kind": "demerger_partial",
"report_waiver": {
"summary": "Les actionnaires des soci\u00E9t\u00E9s participantes renoncent explicitement aux rapports pr\u00E9vus \u00E0 l\u0027article 12:62 du CSA, conform\u00E9ment \u00E0 l\u0027article 12:65 du CSA.",
"articles": [
"12:65"
]
},
"restructuring": {
"parties": [
{
"kbo": "0861.155.805",
"name": "Baxter Belgium SRL",
"role": "demerged",
"address": "Boulevard Ren\u00E9 Branquart 80(L), 7860 Lessines",
"is_foreign": false,
"legal_form": "SRL",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0804.183.349",
"name": "Vantive Belgium SRL",
"role": "recipient",
"address": "Boulevard d\u0027Angleterre 2, B-1420 Braine-L\u0027Alleud",
"is_foreign": false,
"legal_form": "SRL",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"12:4",
"12:8",
"12:59",
"12:65"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2023-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 2647565,
"real_estate_included": false,
"patrimony_description": "Le transfert concerne le Vantive Business, y compris les actifs et passifs exclusivement li\u00E9s \u00E0 cette activit\u00E9, tels que les contrats clients et fournisseurs, les inventaires, les livres et registres, les cr\u00E9ances et dettes li\u00E9es \u00E0 l\u0027activit\u00E9, les droits sur les produits m\u00E9dicaux, les licences r\u00E9glementaires, les droits de propri\u00E9t\u00E9 intellectuelle (\u00E0 l\u0027exception des marques et brevets), et les dro",
"equity_transferred_eur": 2647565.78,
"accounting_effective_date": "2024-01-01"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "Baxter Belgium",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Herman Jacobs",
"org_rep_person_name": null
},
"summary_narrative": "Le pr\u00E9sent projet de scission partielle concerne la s\u00E9paration du Vantive Business de Baxter Belgium SRL, une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e belge, vers Vantive Belgium SRL, \u00E9galement une soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e belge. L\u0027op\u00E9ration, conforme \u00E0 l\u0027article 12:8 juncto 12:59 du Code des soci\u00E9t\u00E9s et associations, vise \u00E0 transf\u00E9rer les actifs et passifs exclusivement li\u00E9s \u00E0 l\u0027activit\u00E9 de soins r\u00E9naux et de th\u00E9rapies aigu\u00EBs, sans dissolution de la soci\u00E9t\u00E9 \u00E0 scinder. Les actionnaires de Baxter Belgium recevront 2.647.565 nouvelles actions de Vantive Belgium en contrepartie de l\u0027apport du Van",
"co_filed_documents": [
"Projet de scission partielle"
],
"detected_real_type": "demerger_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}28-07-2023 4 bestuurders benoemd, 1 ontslagnemend
- Annelies Bryon, Administrateur de catégorie a
- Brecht Gheskiere, Administrateur de catégorie b
- Guy In 't Ven, Administrateur de catégorie b
- Serge Vandermotten, Administrateur de catégorie b
- Vanessa Counaert, Administrateur de catégorie b
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Vanessa Counaert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Annelies Bryon",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Brecht Gheskiere",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Guy In \u0027t Ven",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Serge Vandermotten",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}06-06-2023 2 bestuurders benoemd, 2 ontslagnemend
- Herman Jacobs, Administrateur de catégorie a
- Vanessa Counaert, Administrateur de catégorie b
- Marc Bleiman, Administrateur de catégorie b
- Filip Luypaert, Administrateur de catégorie b
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Marc Bleiman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Filip Luypaert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Herman Jacobs",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Vanessa Counaert",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}16-09-2022 2 ontslagnemend
- Lucille Levi, Bestuurder
- Dimitri Pas, Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Lucille Levi",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Dimitri Pas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}16-09-2022 Romain Seffer benoemd tot commissaire
- Romain Seffer, Commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Romain Seffer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}24-08-2021 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e (SRL)",
"old": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"changed": false
}
}12-05-2021 Bhevan Chandrasena neemt ontslag als administrateur de catégorie b
- Bhevan Chandrasena, Administrateur de catégorie b
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Bhevan Chandrasena",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}03-02-2021 1 bestuurder benoemd, 1 ontslagnemend
- Vanessa Counaert, Bestuurder
- Dimitri Pas, Administrateur de catégorie b
Technische details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Vanessa Counaert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Dimitri Pas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}03-02-2021 1 bestuurder benoemd, 1 ontslagnemend
- Romain Seffer, Commissaire
- Alexis Van Bavel, Commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Romain Seffer",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaire",
"person": {
"rrn": null,
"name": "Alexis Van Bavel",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}26-05-2020 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
},
"legal_form_change": {
"new": "",
"old": "SOCIETE A RESPONSABILITE LIMITEE",
"changed": false
}
}16-01-2020 1 bestuurder benoemd, 1 ontslagnemend
- Herman Jacobs, Gérant de catégorie a
- Anne Charlier, Gérant de catégorie a
Technische details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Anne Charlier",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Herman Jacobs",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}18-12-2019 Pricewaterhouse Coopers reviseurs d'entreprises benoemd tot auditor
- Pricewaterhouse Coopers reviseurs d'entreprises, Auditor
Technische details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "Pricewaterhouse Coopers reviseurs d\u0027entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}20-06-2019 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"old": "Soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e",
"changed": false
}
}07-06-2019 4 bestuurders benoemd
- Lucille Levi, Gérant
- Marc Bleiman, Gérant
- Dimitri Pas, Gérant
- Filip Luypaert, Gérant
Technische details
{
"events": [
{
"kind": "director_in",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Lucille Levi",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Marc Bleiman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Dimitri Pas",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Filip Luypaert",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}21-03-2019 4 bestuurders benoemd, 1 ontslagnemend
- Anne Charlier, Gérant de catégorie a
- Lucille Levi, Gérant de catégorie b
- Marc Bleiman, Gérant de catégorie b
- Dimitri Pas, Gérant de catégorie b
- Frédéric Hoffmann, Gérant
Technische details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Fr\u00E9d\u00E9ric Hoffmann",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Anne Charlier",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Lucille Levi",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Marc Bleiman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Dimitri Pas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}18-11-2016 1 bestuurder benoemd, 1 ontslagnemend
- Filip Luypaert, Gérant de catégorie b
- Anne-Marie Liégeois, Gérant de catégorie b
Technische details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Anne-Marie Li\u00E9geois",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Filip Luypaert",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}18-08-2016 Pricewaterhouse Coopers reviseurs d'entreprises benoemd tot auditor
- Pricewaterhouse Coopers reviseurs d'entreprises, Auditor
Technische details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "Pricewaterhouse Coopers reviseurs d\u0027entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}20-05-2016 2 bestuurders benoemd
- Anne Charlier, Gérant de catégorie b
- Bhevan Chandrasena, Gérant de catégorie b
Technische details
{
"events": [
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Anne Charlier",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Bhevan Chandrasena",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}11-05-2016 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 11/05/2016 · Association Générale de l'Industrie du Médicament
- Filing: 29/04/2016 · Association Générale de l'Industrie du Médicament
- General meeting: 18/03/2016 · Association Générale de l'Industrie du Médicament
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Roche S.A.
- Officer appointment: role: administrateur, start_date: 2016-03-18 · Chiesi S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · MSD Belgium S.A.
- Officer reappointment: role: administrateur, start_date: 2016-03-18 · UCB Belgium S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · AstraZeneca S.A.
- Officer resignation: date: 2016-03-18, role: administrateur · Baxter Belgium SPRL
- Officer resignation: date: 2016-03-18, role: administrateur · Bracco Imaging Europe B.V.
- Statute amendment: article: 14, description: Poids des votes, procuration et procédure de vote · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 16, description: Composition du Conseil d'administration · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 21, description: Mandats · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 27ter, description: Organes (groupe pharma.be animal health) · Association Générale de l'Industrie du Médicament
- Statute amendment: article: 33, description: Conditions d'admission et durée de mandat exceptionnelle · Association Générale de l'Industrie du Médicament
Technische details
{
"facts": [
{
"date": "2016-05-11",
"type": "publication",
"quote": "Bijlagen bij het Belgisch. Staatshlad -11/05/2016-",
"value": "11/05/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-04-29",
"type": "filing",
"quote": "neergelegd/entvangen op 29 APR, 2016",
"value": "29/04/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 18 MARS 2016",
"value": "18/03/2016",
"object": null,
"subject": "e1"
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 1. Roche S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_appointment",
"quote": "Nomination de: 2. Chiesi S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. MSD Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. UCB Belgium S.A.",
"value": {
"role": "administrateur",
"start_date": "2016-03-18"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "administrateur",
"start_date": "18/03/2016"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 1. AstraZeneca S.A.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 2. Baxter Belgium SPRL",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"date": "2016-03-18",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 3. Bracco Imaging Europe B.V.",
"value": {
"date": "2016-03-18",
"role": "administrateur"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"date": "18/03/2016",
"role": "administrateur"
}
},
{
"type": "statute_amendment",
"quote": "article 14. Poids des votes, procuration et proc\u00E9dure de vote",
"value": {
"article": "14",
"description": "Poids des votes, procuration et proc\u00E9dure de vote"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 16. Composition",
"value": {
"article": "16",
"description": "Composition du Conseil d\u0027administration"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 21. Mandats",
"value": {
"article": "21",
"description": "Mandats"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "Article 27ter. Organes",
"value": {
"article": "27ter",
"description": "Organes (groupe pharma.be animal health)"
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "article 33.",
"value": {
"article": "33",
"description": "Conditions d\u0027admission et dur\u00E9e de mandat exceptionnelle"
},
"object": null,
"subject": "e1"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 16790,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"legal_form": "Association sans But Lucratif",
"short_name": "AGIM"
}
},
{
"id": "e2",
"kbo": "0403.088.151",
"kind": "company",
"name": "Roche S.A.",
"attrs": {
"seat": "rue Dante 75, 1070 Anderlecht"
}
},
{
"id": "e3",
"kbo": "0826.654.883",
"kind": "company",
"name": "Chiesi S.A.",
"attrs": {
"seat": "avenue du Bourget 44, 1130 Haren (Bruxelles)"
}
},
{
"id": "e4",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium S.A.",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Woluwe-Saint-Lambert"
}
},
{
"id": "e5",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Belgium S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Anderlecht"
}
},
{
"id": "e6",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Uccle"
}
},
{
"id": "e7",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium SPRL",
"attrs": {
"seat": "boulevard d\u0027Angleterre 2-4, 1420 Braine l\u0027Alleud"
}
},
{
"id": "e8",
"kbo": "0892.349.322",
"kind": "company",
"name": "Bracco Imaging Europe B.V.",
"attrs": {
"seat": "avenue Pasteur 6, 1300 Wavre"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Catherine Rutten",
"attrs": {
"role": "CEO charg\u00E9 de la gestion journali\u00E8re"
}
}
]
}15-07-2015 3 bestuurders benoemd, 2 ontslagnemend
- Frederic Hoffmann, Gérant de catégorie a
- Annemarie Liegeois, Gérant de catégorie b
- Herman Jacobs, Gérant de catégorie b
- Filip Chavatte, Gérant
- Damien Bailly, Gérant
Technische details
{
"events": [
{
"kind": "director_out",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Filip Chavatte",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "g\u00E9rant",
"person": {
"rrn": null,
"name": "Damien Bailly",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie A",
"person": {
"rrn": null,
"name": "Frederic Hoffmann",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Annemarie Liegeois",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "g\u00E9rant de cat\u00E9gorie B",
"person": {
"rrn": null,
"name": "Herman Jacobs",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "Baxter Belgium"
}
}08-05-2013 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 08/05/2013 · Algemene Vereniging van de Geneesmiddelenindustrie
- Filing: 26/04/2013 · Algemene Vereniging van de Geneesmiddelenindustrie
- General meeting: 22/03/2013 · Algemene Vereniging van de Geneesmiddelenindustrie
- Officer appointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · AstraZeneca N.V.
- Officer appointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · Kela Pharma N.V.
- Officer reappointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · Baxter Belgium BVBA
- Officer reappointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · MSD Belgium BVBA
- Officer reappointment: role: lid van de Raad van Bestuur, start_date: 2013-03-22 · UCB Pharma N.V.
- Officer resignation: role: lid van de Raad van Bestuur, end_date: 2013-03-22 · Bayer Healthcare N.V.
- Officer resignation: role: lid van de Raad van Bestuur, end_date: 2013-03-22 · Ferring N.V.
Technische details
{
"facts": [
{
"date": "2013-05-08",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 08/05/2013",
"value": "08/05/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-04-26",
"type": "filing",
"quote": "2 6 APR 2013",
"value": "26/04/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-03-22",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 22 MAART 2013",
"value": "22/03/2013",
"object": null,
"subject": "e1"
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Benoeming van: 1. AstraZeneca N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Benoeming van: 2. Kela Pharma N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e3",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 1. Baxter Belgium BVBA",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e4",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 2. MSD Belgium BVBA",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e5",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Herbenoeming van: 3. UCB Pharma N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "2013-03-22"
},
"object": "e1",
"subject": "e6",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"start_date": "22/03/2013"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 1. Bayer Healthcare N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"end_date": "2013-03-22"
},
"object": "e1",
"subject": "e7",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"end_date": "22/03/2013"
}
},
{
"type": "officer_resignation",
"quote": "Ontslag van: 2. Ferring N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"end_date": "2013-03-22"
},
"object": "e1",
"subject": "e8",
"_value_raw": {
"role": "lid van de Raad van Bestuur",
"end_date": "22/03/2013"
}
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1598,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
"legal_form": "Vereniging zonder winstoogmerk",
"short_name": "AVGI"
}
},
{
"id": "e2",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca N.V.",
"attrs": {
"seat": "Egide Van Ophemstraat 110, 1180 Brussel"
}
},
{
"id": "e3",
"kbo": "0407.326.754",
"kind": "company",
"name": "Kela Pharma N.V.",
"attrs": {
"seat": "Industriepark West 68, 9100 Sint-Niklaas"
}
},
{
"id": "e4",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium BVBA",
"attrs": {
"seat": "Parc de l\u0027Aliance, Boulevard d\u0027Angleterre 2-4, 1420 Braine-l\u0027Alleud"
}
},
{
"id": "e5",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium BVBA",
"attrs": {
"seat": "Lynx Binnenhof 5, 1200 Brussel"
}
},
{
"id": "e6",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Brussel"
}
},
{
"id": "e7",
"kbo": "0400.948.213",
"kind": "company",
"name": "Bayer Healthcare N.V.",
"attrs": {
"seat": "J.E. Mommaertslaan 14, 1831 D\u00EDegem"
}
},
{
"id": "e8",
"kbo": "0428.038.135",
"kind": "company",
"name": "Ferring N.V.",
"attrs": {
"seat": "Capucienenlaan 93C, 9300 Aalst"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {
"role": "Algemeen Directeur belast met het dagelijks bestuur"
}
}
]
}08-05-2013 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 08/05/2013
- Filing: 26/04/2013
- General meeting: 22/03/2013
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · AstraZeneca S.A.
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · Kela Pharma S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · Baxter Belgium S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · MSD Belgium SPRL
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2013-03-22 · UCB Pharma S.A.
- Officer resignation: date: 2013-03-22, role: Membre du Conseil d'administration · Bayer Healthcare S.A.
- Officer resignation: date: 2013-03-22, role: Membre du Conseil d'administration · Ferring S.A.
- Filing representative: role: Directeur général chargé de la gestion journalière · Leo Neels
Technische details
{
"facts": [
{
"date": "2013-05-08",
"type": "publication",
"quote": "Bi s ijlagen bij het Belgisch Staatsblad - 08/05/2013 - Annexes du Moniteur belge",
"value": "08/05/2013",
"object": null,
"subject": null
},
{
"date": "2013-04-26",
"type": "filing",
"quote": "2 6 APR 2013 Greffe",
"value": "26/04/2013",
"object": null,
"subject": null
},
{
"date": "2013-03-22",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 22 MARS 2013",
"value": "22/03/2013",
"object": null,
"subject": null
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Nomination de: 1. AstraZeneca S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e1",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_appointment",
"quote": "Nomination de: 2. Kela Pharma S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 1. Baxter Belgium S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 2. MSD Belgium SPRL",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de: 3. UCB Pharma S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2013-03-22"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "22/03/2013"
}
},
{
"date": "2013-03-22",
"type": "officer_resignation",
"quote": "D\u00E9mission de: 1. Bayer Healthcare S.A.",
"value": {
"date": "2013-03-22",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e6",
"_value_raw": {
"date": "22/03/2013",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2013-03-22",
"type": "officer_resignation",
"quote": "D\u00E9mission de: 2. Ferring S.A.",
"value": {
"date": "2013-03-22",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e7",
"_value_raw": {
"date": "22/03/2013",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"type": "filing_representative",
"quote": "Leo Neels Directeur g\u00E9n\u00E9ral charg\u00E9 de la gestion journali\u00E8re",
"value": {
"role": "Directeur g\u00E9n\u00E9ral charg\u00E9 de la gestion journali\u00E8re"
},
"object": null,
"subject": "e8"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1656,
"truncated": false,
"completeness_doubt": [
"Main company identity: Name \u0027Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament\u0027 (AGIM), KBO \u00270407.622.902\u0027, Legal form \u0027Association sans But Lucratif\u0027, Seat \u0027chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES\u0027"
]
},
"entities": [
{
"id": "e1",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Bruxelles"
}
},
{
"id": "e2",
"kbo": "0407.326.754",
"kind": "company",
"name": "Kela Pharma S.A.",
"attrs": {
"seat": "Industriepark West 68, 9100 Sint-Niklaas"
}
},
{
"id": "e3",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium S.A.",
"attrs": {
"seat": "Parc de l\u0027Alliance, Boulevard d\u0027Angleterre 2-4, 1420 Braine-L\u0027Alleud"
}
},
{
"id": "e4",
"kbo": "0406.820.770",
"kind": "company",
"name": "MSD Belgium SPRL",
"attrs": {
"seat": "Clos du Lynx 5, 1200 Bruxelles"
}
},
{
"id": "e5",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Bruxelles"
}
},
{
"id": "e6",
"kbo": "0400.948.213",
"kind": "company",
"name": "Bayer Healthcare S.A.",
"attrs": {
"seat": "J.E. Mommaertslaan 14, 1831 Diegem"
}
},
{
"id": "e7",
"kbo": "0428.038.135",
"kind": "company",
"name": "Ferring S.A.",
"attrs": {
"seat": "Capucienenlaan 93C, 9300 Aalst"
}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {}
}
]
}03-01-2012 2 bestuurders benoemd
- Jean-Michel Heusdens, Benelux tax manager
- Philippe Lodomez, Accounting director
Technische details
{
"events": [
{
"kind": "director_in",
"role": "Benelux Tax Manager",
"person": {
"rrn": null,
"name": "Jean-Michel Heusdens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Accounting Director",
"person": {
"rrn": null,
"name": "Philippe Lodomez",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0861.155.805",
"name_full": "BAXTER BELGIUM"
}
}31-05-2010 General meeting · Member admission · Member resignation · Board meeting
- Publication: 31/05/2010
- Filing: 19-05-2010
- General meeting: 26/03/2010
- Member admission: role: lid van de Raad van Bestuur, start_date: 26/03/2010 · AstraZeneca N.V.
- Member admission: role: lid van de Raad van Bestuur, start_date: 26/03/2010 · Baxter Belgium BVBA
- Member admission: role: lid van de Raad van Bestuur, start_date: 26/03/2010 · Bayer Healthcare N.V.
- Member admission: role: lid van de Raad van Bestuur, start_date: 26/03/2010 · Ferring N.V.
- Member admission: role: lid van de Raad van Bestuur, start_date: 26/03/2010 · Merck Sharp & Dohme BV
- Member admission: role: lid van de Raad van Bestuur, start_date: 26/03/2010 · UCB Pharma N.V.
- Member resignation: date: 26/03/2010, role: lid van de Raad van Bestuur · Schering-Plough N.V.
- Member resignation: date: 26/03/2010, role: lid van de Raad van Bestuur · Wyeth Pharmaceuticals N.V.
- Board meeting: 21/04/2010
- Officer appointment: role: voorzitter van de Raad van Bestuur, term: tot de Algemene Vergadering van maart 2011, start_date: 2010-04-21 · Merck Sharp & Dohme BV
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, term: tot de Algemene Vergadering van maart 2011, start_date: 2010-04-21 · Pfizer
- Officer appointment: role: voorzitter van de Raad van Bestuur, term: tot de Algemene Vergadering van maart 2012, start_date: maart 2011 · Pfizer
- Officer appointment: role: ondervoorzitter van de Raad van Bestuur, term: tot de Algemene Vergadering van maart 2012, start_date: maart 2011 · Merck Sharp & Dohme BV
- Power of attorney · Jan Van Acker
- Power of attorney · Kris Westelinck
Technische details
{
"facts": [
{
"date": "2010-05-31",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 31/05/2010",
"value": "31/05/2010",
"object": null,
"subject": null
},
{
"date": "2010-05-19",
"type": "filing",
"quote": "BRUSSEL 19-05-2010 Griffie",
"value": "19-05-2010",
"object": null,
"subject": null
},
{
"date": "2010-03-26",
"type": "general_meeting",
"quote": "ALGEMENE VERGADERING VAN 26 MAART 2010",
"value": "26/03/2010",
"object": null,
"subject": null
},
{
"date": "2010-03-26",
"type": "member_admission",
"quote": "Verkiezing van 6 nieuwe leden van de Raad van Bestuur ... 1. AstraZeneca N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "26/03/2010"
},
"object": null,
"subject": "e1"
},
{
"date": "2010-03-26",
"type": "member_admission",
"quote": "Verkiezing van 6 nieuwe leden van de Raad van Bestuur ... 2. Baxter Belgium BVBA",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "26/03/2010"
},
"object": null,
"subject": "e2"
},
{
"date": "2010-03-26",
"type": "member_admission",
"quote": "Herbenoeming van: 1. Bayer Healthcare N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "26/03/2010"
},
"object": null,
"subject": "e3"
},
{
"date": "2010-03-26",
"type": "member_admission",
"quote": "Herbenoeming van: 2. Ferring N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "26/03/2010"
},
"object": null,
"subject": "e4"
},
{
"date": "2010-03-26",
"type": "member_admission",
"quote": "Herbenoeming van: 3. Merck Sharp \u0026 Dohme BV",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "26/03/2010"
},
"object": null,
"subject": "e5"
},
{
"date": "2010-03-26",
"type": "member_admission",
"quote": "Herbenoeming van: 4. UCB Pharma N.V.",
"value": {
"role": "lid van de Raad van Bestuur",
"start_date": "26/03/2010"
},
"object": null,
"subject": "e6"
},
{
"date": "2010-03-26",
"type": "member_resignation",
"quote": "Ontslag van: 1. Schering-Plough N.V.",
"value": {
"date": "26/03/2010",
"role": "lid van de Raad van Bestuur"
},
"object": null,
"subject": "e7"
},
{
"date": "2010-03-26",
"type": "member_resignation",
"quote": "Ontslag van: 2. Wyeth Pharmaceuticals N.V.",
"value": {
"date": "26/03/2010",
"role": "lid van de Raad van Bestuur"
},
"object": null,
"subject": "e8"
},
{
"date": "2010-04-21",
"type": "board_meeting",
"quote": "VERGADERING VAN DE RAAD VAN BESTUUR VAN 21 APRIL 2010",
"value": "21/04/2010",
"object": null,
"subject": null
},
{
"date": "2010-04-21",
"type": "officer_appointment",
"quote": "Op de Raad van Bestuur van 21 april 2010 werd Merck Sharp \u0026 Dohme ... verkozen tot nieuwe voorzitter ... tot de Algemene Vergadering van maart 2011",
"value": {
"role": "voorzitter van de Raad van Bestuur",
"term": "tot de Algemene Vergadering van maart 2011",
"start_date": "2010-04-21"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "voorzitter van de Raad van Bestuur",
"term": "tot de Algemene Vergadering van maart 2011",
"start_date": "21/04/2010"
}
},
{
"date": "2010-04-21",
"type": "officer_appointment",
"quote": "Op de Raad van Bestuur van 21 april 2010 werd ... Pfizer ... verkozen tot nieuwe ondervoorzitter ... tot de Algemene Vergadering van maart 2011",
"value": {
"role": "ondervoorzitter van de Raad van Bestuur",
"term": "tot de Algemene Vergadering van maart 2011",
"start_date": "2010-04-21"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "ondervoorzitter van de Raad van Bestuur",
"term": "tot de Algemene Vergadering van maart 2011",
"start_date": "21/04/2010"
}
},
{
"type": "officer_appointment",
"quote": "werd Pfizer ... verkozen tot nieuwe voorzitter ... vanaf de Algemene Vergadering van maart 2011 tot de Algemene Vergadering van maart 2012",
"value": {
"role": "voorzitter van de Raad van Bestuur",
"term": "tot de Algemene Vergadering van maart 2012",
"start_date": "maart 2011"
},
"object": null,
"subject": "e9"
},
{
"type": "officer_appointment",
"quote": "werd ... Merck Sharp \u0026 Dohme ... verkozen tot nieuwe ondervoorzitter vanaf de Algemene Vergadering van maart 2011 tot de Algemene Vergadering van maart 2012",
"value": {
"role": "ondervoorzitter van de Raad van Bestuur",
"term": "tot de Algemene Vergadering van maart 2012",
"start_date": "maart 2011"
},
"object": null,
"subject": "e5"
},
{
"type": "power_of_attorney",
"quote": "Merck Sharp \u0026 Dohme, vertegenwoordigd door Jan Van Acker",
"value": null,
"object": "e5",
"subject": "e10"
},
{
"type": "power_of_attorney",
"quote": "Pfizer, vertegenwoordigd door Kris Westelinck",
"value": null,
"object": "e9",
"subject": "e11"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 2447,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca N.V.",
"attrs": {
"seat": "Egide Van Ophemstraat 110, 1180 Brussel"
}
},
{
"id": "e2",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium BVBA",
"attrs": {
"seat": "Parc de l\u0027Alliance, Boulevard d\u0027Angleterre 2-4, 1420 Braine-l\u0027Alleud"
}
},
{
"id": "e3",
"kbo": "0400.948.213",
"kind": "company",
"name": "Bayer Healthcare N.V.",
"attrs": {
"seat": "J.E. Mommaertslaan 14, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0428.038.135",
"kind": "company",
"name": "Ferring N.V.",
"attrs": {
"seat": "Hopmarkt 9 bus 3, 9300 Aalst"
}
},
{
"id": "e5",
"kbo": "0401.988.586",
"kind": "company",
"name": "Merck Sharp \u0026 Dohme BV",
"attrs": {
"seat": "Waterloosesteenweg 1135, 1180 Brussel"
}
},
{
"id": "e6",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma N.V.",
"attrs": {
"seat": "Researchdreef 60, 1070 Brussel"
}
},
{
"id": "e7",
"kbo": "0406.820.770",
"kind": "company",
"name": "Schering-Plough N.V.",
"attrs": {
"seat": "Stallestraat 73, 1180 Brussel"
}
},
{
"id": "e8",
"kbo": "0415.965.989",
"kind": "company",
"name": "Wyeth Pharmaceuticals N.V.",
"attrs": {
"seat": "Parc Scientific Einstein, rue du Bosquet 15, 1348 Louvain-La-Neuve"
}
},
{
"id": "e9",
"kbo": null,
"kind": "company",
"name": "Pfizer",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Jan Van Acker",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Kris Westelinck",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {}
},
{
"id": "e13",
"kbo": "0407.622.902",
"kind": "company",
"name": "Algemene Vereniging van de Geneesmiddelenindustrie",
"attrs": {
"seat": "Terhulpsesteenweg 166, 1170 BRUSSEL",
"legal_form": "Vereniging zonder winstoogmerk",
"short_name": "AVGI"
}
}
]
}31-05-2010 General meeting · Officer appointment · Officer reappointment · Officer resignation
- Publication: 31/05/2010
- Filing: 19-05-2010
- General meeting: 26/03/2010
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2010-03-26 · AstraZeneca S.A.
- Officer appointment: role: Membre du Conseil d'administration, start_date: 2010-03-26 · Baxter Belgium S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2010-03-26 · Bayer Healthcare S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2010-03-26 · Ferring S.A.
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2010-03-26 · Merck Sharp & Dohme BV
- Officer reappointment: role: Membre du Conseil d'administration, start_date: 2010-03-26 · UCB Pharma S.A.
- Officer resignation: date: 2010-03-26, role: Membre du Conseil d'administration · Schering-Plough S.A.
- Officer resignation: date: 2010-03-26, role: Membre du Conseil d'administration · Wyeth Pharmaceuticals S.A.
- Board meeting: 21/04/2010
- Officer appointment: role: Président du Conseil d'administration, term: jusqu'à l'Assemblée générale de mars 2011, start_date: 2010-04-21 · Merck Sharp & Dohme BV
- Officer appointment: role: Vice-Président du Conseil d'administration, term: jusqu'à l'Assemblée générale de mars 2011, start_date: 2010-04-21 · Pfizer
- Officer appointment: role: Président du Conseil d'administration, term: jusqu'à l'Assemblée générale de mars 2012, start_date: mars 2011 · Pfizer
- Officer appointment: role: Vice-Président du Conseil d'administration, term: jusqu'à l'Assemblée générale de mars 2012, start_date: mars 2011 · Merck Sharp & Dohme BV
Technische details
{
"facts": [
{
"date": "2010-05-31",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 31/05/2010",
"value": "31/05/2010",
"object": null,
"subject": null
},
{
"date": "2010-05-19",
"type": "filing",
"quote": "BRUXELLES 19-05-2010",
"value": "19-05-2010",
"object": null,
"subject": null
},
{
"date": "2010-03-26",
"type": "general_meeting",
"quote": "ASSEMBLEE GENERALE DU 26 MARS 2010",
"value": "26/03/2010",
"object": null,
"subject": null
},
{
"date": "2010-03-26",
"type": "officer_appointment",
"quote": "Nomination de: 1. AstraZeneca S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2010-03-26"
},
"object": null,
"subject": "e1",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "26/03/2010"
}
},
{
"date": "2010-03-26",
"type": "officer_appointment",
"quote": "Nomination de: 2. Baxter Belgium S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2010-03-26"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "26/03/2010"
}
},
{
"date": "2010-03-26",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 1. Bayer Healthcare S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2010-03-26"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "26/03/2010"
}
},
{
"date": "2010-03-26",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 2. Ferring S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2010-03-26"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "26/03/2010"
}
},
{
"date": "2010-03-26",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 3. Merck Sharp \u0026 Dohme BV",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2010-03-26"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "26/03/2010"
}
},
{
"date": "2010-03-26",
"type": "officer_reappointment",
"quote": "Reconduction de la nomination de : 4. UCB Pharma S.A.",
"value": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "2010-03-26"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "Membre du Conseil d\u0027administration",
"start_date": "26/03/2010"
}
},
{
"date": "2010-03-26",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 1. Schering-Plough S.A.",
"value": {
"date": "2010-03-26",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e7",
"_value_raw": {
"date": "26/03/2010",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2010-03-26",
"type": "officer_resignation",
"quote": "D\u00E9mission de : 2. Wyeth Pharmaceuticals S.A.",
"value": {
"date": "2010-03-26",
"role": "Membre du Conseil d\u0027administration"
},
"object": null,
"subject": "e8",
"_value_raw": {
"date": "26/03/2010",
"role": "Membre du Conseil d\u0027administration"
}
},
{
"date": "2010-04-21",
"type": "board_meeting",
"quote": "REUNION DU CONSEIL D\u0027ADMINISTRATION DU 21 AVRIL 2010",
"value": "21/04/2010",
"object": null,
"subject": null
},
{
"date": "2010-04-21",
"type": "officer_appointment",
"quote": "Merck Sharp \u0026 Dohme ... a \u00E9t\u00E9 \u00E9lue nouveau Pr\u00E9sident ... jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011",
"value": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011",
"start_date": "2010-04-21"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011",
"start_date": "21/04/2010"
}
},
{
"date": "2010-04-21",
"type": "officer_appointment",
"quote": "Pfizer, repr\u00E9sent\u00E9e par Kris Westelinck, a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident ... jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011",
"start_date": "2010-04-21"
},
"object": null,
"subject": "e13",
"_value_raw": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011",
"start_date": "21/04/2010"
}
},
{
"type": "officer_appointment",
"quote": "Pfizer, repr\u00E9sent\u00E9e par Kris Westelinck, a \u00E9t\u00E9 \u00E9lue nouveau Pr\u00E9sident ... \u00E0 partir de l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011 jusqu\u0027\u00E0 l\u0027Assembl\u00E8e g\u00E9n\u00E9rale de mars 2012",
"value": {
"role": "Pr\u00E9sident du Conseil d\u0027administration",
"term": "jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2012",
"start_date": "mars 2011"
},
"object": null,
"subject": "e13"
},
{
"type": "officer_appointment",
"quote": "Merck Sharp \u0026 Dohme, repr\u00E9sent\u00E9e par Jan Van Acker, a \u00E9t\u00E9 \u00E9lue nouveau Vice-Pr\u00E9sident ... \u00E0 partir de l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2011 jusqu\u0027\u00E0 l\u0027Assembl\u00E8e g\u00E9n\u00E9rale de mars 2012",
"value": {
"role": "Vice-Pr\u00E9sident du Conseil d\u0027administration",
"term": "jusqu\u0027\u00E0 l\u0027Assembl\u00E9e g\u00E9n\u00E9rale de mars 2012",
"start_date": "mars 2011"
},
"object": null,
"subject": "e5"
}
],
"act_meta": {
"outcome": "corrected",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 2510,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0400.165.679",
"kind": "company",
"name": "AstraZeneca S.A.",
"attrs": {
"seat": "rue Egide Van Ophem 110, 1180 Bruxelles"
}
},
{
"id": "e2",
"kbo": "0861.155.805",
"kind": "company",
"name": "Baxter Belgium S.A.",
"attrs": {
"seat": "Parc de l\u0027Alliance, Boulevard d\u0027Angleterre 2-4, 1420 Braine-L\u0027Alleud"
}
},
{
"id": "e3",
"kbo": "0400.948.213",
"kind": "company",
"name": "Bayer Healthcare S.A.",
"attrs": {
"seat": "J.E. Mommaertslaan 14, 1831 Diegem"
}
},
{
"id": "e4",
"kbo": "0428.038.135",
"kind": "company",
"name": "Ferring S.A.",
"attrs": {
"seat": "Hopmarkt 9 bus 3, 9300 Aalst"
}
},
{
"id": "e5",
"kbo": "0401.988.586",
"kind": "company",
"name": "Merck Sharp \u0026 Dohme BV",
"attrs": {
"seat": "chauss\u00E9e de Waterloo 1135, 1180 Bruxelles"
}
},
{
"id": "e6",
"kbo": "0403.096.168",
"kind": "company",
"name": "UCB Pharma S.A.",
"attrs": {
"seat": "All\u00E9e de la Recherche 60, 1070 Bruxelles"
}
},
{
"id": "e7",
"kbo": "0406.820.770",
"kind": "company",
"name": "Schering-Plough S.A.",
"attrs": {
"seat": "rue de Stalle 73, 1180 Bruxelles"
}
},
{
"id": "e8",
"kbo": "0415.965.989",
"kind": "company",
"name": "Wyeth Pharmaceuticals S.A.",
"attrs": {
"seat": "Parc Scientific Einstein, rue du Bosquet 15, 1348 Louvain-La-Neuve"
}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Jan Van Acker",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Kris Westelinck",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Leo Neels",
"attrs": {}
},
{
"id": "e12",
"kbo": "0407.622.902",
"kind": "company",
"name": "Association G\u00E9n\u00E9rale de l\u0027Industrie du M\u00E9dicament",
"attrs": {
"seat": "chauss\u00E9e de La Hulpe 166, 1170 BRUXELLES",
"short_name": "AGIM"
}
},
{
"id": "e13",
"kbo": null,
"kind": "company",
"name": "Pfizer",
"attrs": {}
}
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | BAXTER BELGIUM |